Acceleron Pharma (XLRN +1.6%) is up on below-average volume on the heels of its announcement of positive preliminary data from Part 1 of its ... read more
Acceleron's ACE-083 shows positive effect in mid-stage study in inherited neurological disorder ...
Acceleron’s ACE-083 shows positive effect in mid-stage study in inherited neurological disorder …